Biological markers in the diagnosis of the different forms of renal osteodystrophy

American Journal of the Medical Sciences

Volumn 320, Issue 2, 2000, Pages 85-89

  Ferreira, Aníbal ^a   Drüeke, Tilman B ^b  

^a HOSPITAL CURRY CABRAL   (Portugal)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Bone biopsies; Renal osteodystrophy; Serum markers of bone remodeling; 2 Microglobulin

Indexed keywords

ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; BIOLOGICAL MARKER; CYTOKINE; CYTOKINE RECEPTOR; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN C PROTEINASE; PYRIDINOLINE;

BONE REMODELING; BONE TURNOVER; CELL ACTIVATION; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; HORMONE BLOOD LEVEL; MORBIDITY; MORPHOMETRICS; OSSIFICATION; OSTEOLYSIS; RELIABILITY; RENAL OSTEODYSTROPHY; SERUM;

EID: 0033843506     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200008000-00004     Document Type: Article

References (42)

1. Renal bone disease 1990: An unmet challenge for the nephrologist
2. Aplastic osteodystrophy without aluminum: The role of 'suppressed' parathyroid function
3. The spectrum of bone disease in end-stage renal failure - An evolving disorder
4. Epidemiology of renal osteodystrophy in iberoamerica
5. Risk of adynamic bone disease in dialyzed patients
6. Trends in renal osteodystrophy: A survey from 1983 to 1995 in a total of 2248 patients
7. The role of bone biopsy in the management of patients with renal osteodystrophy
8. Diagnosis and treatment of aluminium bone disease
9. Side effects of desferrioxamine in dialysis patients
10. Comparison of intact, midregion and carboxy terminal assays for parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients
11. Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
12. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD
13. Invasive versus non-invasive diagnosis of renal bone disease
14. Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
15. Skeletal resistance to PTH in renal failure: Studies in 105 humans subjects
16. PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats
17. Non invasive circulating indicators of bone metabolism in uraemic patients: Can they replace bone biopsy?
18. The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatases and not liver alkaline phosphatase
19. Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients
20. Bone alkaline phosphatase isoenzyme in renal osteodystrophy
21. Low serum levels of alkaline phosphatase of bone origin: A good marker of adynamic bone disease in haemodialysis patients
22. Assessment of renal osteodystrophy in dialysis patients: Use of bone alkaline phosphatase, bone mineral density, and parathyroid ultrasound in comparison with bone histology
23. Measurement of serum osteocalcin with a human-specific two-site immuno-radiometric assay
24. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
25. Procollagen type I C-terminal extension peptide in predialysis chronic renal failure
26. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients
27. Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy
28. Serum type I procollagen peptide: A non-invasive index of bone formation in patients on hemodialysis?
29. Generation of osteoclastic function in mouse bone marrow cultures: Multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for osteoclastic differentiation
30. Development of an immunoassay for human serum osteoclastic tartrate-resistant acid phosphatase
31. Immunoassay of tartrate-resistant acid phosphatase in serum
32. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new marker of bone degradation
33. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: The effect of nandrolone decanoate and hormone replacement therapy
34. An immunoassay for the measurement of free pyridinoline in serum: A marker of bone resorption
35. Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis
36. Relationship between serum β2-microglobulin, bone histology and dialysis membranes in uraemic patients
37. Mechanisms of disease: Renal osteodystrophy
38. Cytokines: Agents provocateurs in haemodialysis?
39. Interleukin-6 is produced by bone and modulated by parathyroid hormone
40. Balance between IL-1β, TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis: Relationships with activation markers of T cells, B cells and monocytes
41. Plasma levels of IL-1α, TNF-α and their specific inhibitors in undialysed chronic renal failure, CAPD and hemodialysis patients
42. Potential role of cytokines in renal osteodystrophy